Systematic review and meta-analysis have shown that CSF ADA cannot differentiate TBM from bacterial meningitis; however, it can improve the diagnosis of TBM at ADA level >8 IU/L, particularly when bacterial infection has been ruled out [21]. This evidence concerns the gene ADA and bacterial meningitis.